N
CMD

Nuveen’s Cantel Medical Corporation CMD Stock Holding History

Nuveen’s Portfolio CMD Stock Details CMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-188,521
Closed -$15.1M – 3637
2021
Q1 		$15.1M Sell
188,521
-7,930
-4% -$619K ﹤0.01% 1531
2020
Q4 		$15.5M Buy
196,451
+20,685
+12% +$1.21M 0.01% 1414
2020
Q3 		$7.72M Sell
175,766
-4,828
-3% -$238K ﹤0.01% 1671
2020
Q2 		$7.99M Buy
180,594
+92,700
+105% +$3.46M ﹤0.01% 1639
2020
Q1 		$3.15M Buy
87,894
+4,522
+5% +$257K ﹤0.01% 1961
2019
Q4 		$5.91M Sell
83,372
-11,480
-12% -$833K ﹤0.01% 1895
2019
Q3 		$7.09M Buy
94,852
+3,025
+3% +$256K ﹤0.01% 1772
2019
Q2 		$7.41M Buy
+91,827
New +$6.46M ﹤0.01% 1774

Nuveen's CMD Position: Q2 2021 in Review

Nuveen sold out of Cantel Medical Corporation (CMD) in Q2 2021, closing a stake of 188,521 shares — an estimated $15.1M sold.

Nuveen first reported a position in CMD in Q2 2019 and held it in 8 quarters. The position peaked at $15.5M in Q4 2020. 0 funds tracked by Wall St. Rank hold CMD as of Q2 2021.

  • Nuveen reported no remaining Cantel Medical Corporation position as of Q2 2021 after selling out during the quarter.
  • Nuveen sold 188,521 Cantel Medical Corporation shares in Q2 2021, an estimated $15.1M.
  • Nuveen first reported a position in Cantel Medical Corporation in Q2 2019 and held it in 8 quarters.
  • Nuveen's Cantel Medical Corporation position peaked at $15.5M in Q4 2020.
  • 0 funds tracked by Wall St. Rank held Cantel Medical Corporation as of Q2 2021.

Based on Nuveen's 13F filing for Q2 2021, filed 16 Aug 2021.